date,title,source
Oct-17-18,Vertex Pharmaceuticals (VRTX) Q3 Earnings Preview: What's Shaping Up?,Zacks
Oct-17-18,CELG vs. VRTX: Which Stock Should Value Investors Buy Now?,Zacks
Oct-18-18,Growth Stocks Smacked Again As Market Correction Intensifies,Investor's Business Daily
Oct-18-18,Vertex Data Presented at North American Cystic Fibrosis Conference (NACFC) Demonstrate Rapid Progress Toward Expanding and Enhancing Options for Treating the Underlying Cause of Cystic Fibrosis,Business Wire
Oct-19-18,Why Proteostasis Therapeutics Tumbled 23.2% on Friday,Motley Fool
Oct-19-18,UAB researchers leading way on drug regimen battling cystic fibrosis,American City Business Journals
Oct-19-18,Why Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Is A Financially Healthy Company,Simply Wall St.
Oct-22-18,Is a Beat in Store for Vertex (VRTX) This Earnings Season?,Zacks
Oct-22-18,What's in Store for Anika Therapeutics (ANIK) in Q3 Earnings?,Zacks
Oct-23-18,"Biotech Stocks Earnings Lineup for Oct 24: VRTX, ALXN & SRPT",Zacks
Oct-24-18,Vertex Pharmaceuticals Inc (VRTX) Q3 2018 Earnings Conference Call Transcript,Motley Fool
Oct-24-18,Vertex Pharmaceuticals (VRTX) Q3 Earnings and Revenues Surpass Estimates,Zacks
Oct-24-18,Vertex: 3Q Earnings Snapshot,Associated Press
Oct-24-18,Vertex Reports Third-Quarter 2018 Financial Results,Business Wire
Oct-24-18,Vertex Pharmaceuticals Q3 Earnings Outlook,Benzinga
Oct-25-18,Edited Transcript of VRTX earnings conference call or presentation 24-Oct-18 8:30pm GMT,Thomson Reuters StreetEvents
Oct-25-18,Vertex (VRTX) Q3 Earnings and Revenues Surpass Estimates,Zacks
Oct-25-18,Today's Research Reports on Trending Tickers: Vertex Pharmaceuticals and Celgene,ACCESSWIRE
Oct-26-18,Edited Transcript of VRTX earnings conference call or presentation 24-Oct-18 8:30pm GMT,Thomson Reuters StreetEvents
Oct-29-18,Vertex Pharmaceuticals Waits to Hit the Triple,Motley Fool
Oct-30-18,Is a Beat in Store for CRISPR (CRSP) This Earnings Season?,Zacks
Oct-31-18,"Biotech Stock Roundup: Celgene, Amgen, Vertex Impress in Q3, DRNA Soars on LLY Deal",Zacks
Nov-01-18,"The Zacks Analyst Blog Highlights: Gilead Sciences, Amgen, Vertex Pharmaceuticals, Celgene and Regeneron Pharmaceuticals",Zacks
Nov-07-18,Cambridge's Editas asks FDA to start gene editing trial,American City Business Journals
Nov-08-18,"Perrigo (PRGO) Beats on Q3 Earnings, Cuts View, Shares Down",Zacks
Nov-08-18,3 Biotech Stocks Poised for Big Rebounds,Investopedia
Nov-09-18,"Celldex (CLDX) Q3 Earnings Beat Estimates, Revenues Miss",Zacks
Nov-14-18,"Analysis: Positioning to Benefit within Vertex Pharmaceuticals, MISONIX, Whiting Petroleum, Kewaunee Scientific, Arotech, and Apollo Commercial Real Estate Finance  Research Highlights Growth, Revenue, and Consolidated Results",GlobeNewswire
